Zinc is one of the few minerals Japan lets a food label directly by fixed wording, and brands abroad notice the neat, government-approved sentences on Japanese shelves. That precision looks appealing next to the vaguer “supports immunity” language allowed elsewhere.
The appeal is real, but the fixed wording is narrower than it looks, and the clinical evidence behind zinc is strongest for one specific use — zinc, mostly as lozenges, taken once a cold has started — not for zinc supplementation in general. This guide explains what Japan’s system actually permits, what independent trials actually show, and how to specify a Japan-made zinc product without overstating either.
Health supplements are foods, not medicines, and are not a substitute for medical treatment. Nothing here is a claim that any product prevents, treats or cures a disease.
💬 Planning a zinc product made in Japan? We check the full formula against Japanese food law first. See Japan-made supplement OEM.
What the research shows
Zinc taken once a cold has started, mostly as lozenges, may shorten it by around two to three days in adults — but the evidence is rated low-certainty, the benefit has not been shown in children, and zinc taken to prevent colds has shown little or no effect.
| Study | Design/What was analysed | Reported result |
|---|---|---|
| Systematic review and meta-analysis, CMAJ 2012 (PMID 22566526) | 17 randomised controlled trials, 2,121 participants, of oral zinc versus placebo or no treatment for the common cold, in adults and children | Zinc shortened cold duration overall (mean difference −1.65 days); the effect held in adults (−2.63 days) but was not significant in children (−0.26 days); adverse events, bad taste and nausea were more common with zinc |
| Individual patient data meta-analysis, British Journal of Clinical Pharmacology 2016 (PMID 27378206) | Three randomised, placebo-controlled trials of zinc acetate lozenges, 199 patients, re-analysed patient by patient | Colds were 2.73–2.94 days shorter than with placebo, against an average cold duration of 7 days in the three trials; the effect did not differ by allergy status, smoking, age or sex |
| Cochrane systematic review, Cochrane Database of Systematic Reviews 2024 (PMID 38719213) | 34 randomised placebo-controlled trials (15 prevention, 19 treatment), 8,526 adults and children; zinc combined with other vitamins, minerals or herbs excluded | Taken for prevention, zinc may have little or no effect on developing a cold; taken as treatment, it may shorten colds by a mean of 2.37 days (low-certainty evidence), with more non-serious adverse events; interventions varied widely between trials |
Two honest caveats follow from these results. First, the benefit is tied to zinc taken as a cold treatment — most often as lozenges — not to zinc supplementation as a general habit, and the 2024 Cochrane review rated even the treatment result low-certainty because the trials varied so widely in zinc form, dose and outcomes. Second, bad taste, nausea and other non-serious side effects were more common in the zinc groups, which matters for a product that depends on a pleasant lozenge experience.
Checked against the published abstracts on 25 September 2026.
What Japanese products say
Japan’s Foods with Nutrient Function Claims (栄養機能食品) system lets a zinc product use one or more of three fixed sentences once the amount per serving falls inside a set daily range, without any premarket approval.
Under Japan’s Consumer Affairs Agency rules (Food Labeling Standards, Appended Table 11 / 食品表示基準 別表第11), zinc qualifies as a Food with Nutrient Function Claims when the daily intake amount stated on the label contains between 2.64 mg and 15 mg of zinc. No notification or approval is needed — the business is simply responsible for meeting the fixed amount range and using only the fixed wording, in full, with the fixed caution.
The three permitted function statements (our translation) are:
- “Zinc is a nutrient necessary for maintaining normal taste perception.”
- “Zinc is a nutrient that helps maintain healthy skin and mucous membranes.”
- “Zinc is a nutrient that is involved in protein and nucleic acid metabolism and helps maintain health.”
The mandatory caution statement (our translation) reads: “This product does not cure disease or further improve health through excessive intake. Excessive zinc intake may interfere with copper absorption, so take care not to over-consume. Follow the daily recommended amount. Infants and young children should avoid this product.”
Two points for a brand abroad:
- The Japanese wording is about taste, skin and general metabolism — not about colds or immunity. The cold-lozenge evidence above sits outside this system entirely; a Japan-labelled zinc product cannot borrow it.
- The mandatory caution about copper absorption and about excluding infants and young children is not optional wording. It has to appear in full alongside the function claim.
💬 Need help mapping the Japanese nutrient-function wording against your own market’s rules? We prepare a comparison with the manufacturing documents. Tell us your market.
Wording that stays on safe ground
Describe zinc by its studied use and dose, and keep any cold-related wording tied to the specific lozenge evidence rather than to zinc generally.
| Safer wording | Wording to avoid |
|---|---|
| ”Zinc acetate lozenges, studied for cold duration in adults" | "Zinc boosts your immune system” or “prevents colds" |
| "Contains zinc” with the amount per serving, inside Japan’s notified range if using the Japanese wording | Naming zinc deficiency, immune disorders, or any disease |
| ”Studied in adults; effect not shown in children” | Implying the same benefit applies to all ages or to low daily doses |
How zinc is formulated
Zinc is a small, stable, inorganic mineral, so the main formulation decisions are about the salt form, the dose, and — for a cold-lozenge product — the format and taste.
| Dosage form | Why brands choose it | What to weigh up |
|---|---|---|
| Hard capsule or tablet | Simple, precise dosing, no taste issue | Not the format used in the cold-lozenge evidence |
| Lozenge | Matches the studied cold-relief use | Zinc has a metallic, sometimes bitter taste at the doses used in trials; flavouring and mouthfeel are real formulation challenges |
| Powder or drink mix | Flexible for combination products | Same taste challenge as lozenges |
Decisions that shape the specification:
- Salt form. Zinc gluconate and zinc citrate show similar absorption (around 61% in young adults in published data), higher than zinc oxide (around 50%). Zinc sulfate and zinc acetate are also common in supplements; zinc acetate is the form used in the pooled lozenge trials above.
- Amount per serving. For a Japanese Foods with Nutrient Function Claims product, the daily amount from the label must sit between 2.64 mg and 15 mg. Japan’s own dietary reference intakes (2025 edition) set the tolerable upper intake level for total zinc intake at 40 mg/day for adult men aged 18–29 and 75 and over, 45 mg/day for men aged 30–74, and 35 mg/day for adult women — figures that matter if the product also carries claims tied to higher-dose research.
- Companion ingredients. Zinc is often combined with vitamin C, other minerals, or botanicals in “immune” formulas. Every companion ingredient needs its own check against Japanese food law.
- Copper interaction. High, sustained zinc intake can reduce copper absorption — the reason behind Japan’s mandatory caution wording and a real formulation consideration for any long-duration zinc product.
The check that comes first
Every ingredient must be permitted in foods in Japan, or a Japanese factory cannot make the product.
Zinc itself is a well-established food mineral in Japan. The risk, as with most mineral and “immune support” formulas, sits in companion botanicals or high-dose combinations that stray into medicinal territory. See the Japan-made supplement OEM page, and compare with our iron and magnesium guides for how the same Foods with Nutrient Function Claims system applies to other minerals.
Before you ask for a quotation
A factory can quote accurately once the zinc form, the amount, the format and the target claim are fixed.
- Zinc salt form (gluconate, citrate, oxide, sulfate or acetate) and amount per serving
- Whether you intend to use Japan’s Foods with Nutrient Function Claims wording, and if so, confirmation the amount falls inside 2.64–15 mg
- Dosage form — capsule, tablet, lozenge or powder — and flavour if a lozenge
- Companion ingredients and their amounts
- Countries you will sell in, and zinc’s status and upper-limit guidance there
- First order and annual volume
💬 Ready to design a Japan-made zinc product? Send us the concept — amount, form, companion ingredients and the countries you will sell in.
Frequently asked questions
1. Does zinc really shorten a cold?
Pooled trials suggest zinc taken once a cold has started, mostly as lozenges, may shorten it by around two to three days in adults, but a 2024 Cochrane review rated this evidence low-certainty. The benefit was not shown in children, and zinc taken to prevent colds showed little or no effect.
2. What can a Japan-made zinc product actually say on its Japanese label?
If the daily amount is between 2.64 mg and 15 mg, it can carry one or more of three fixed sentences about taste, skin and mucous membranes, and protein and nucleic acid metabolism — plus a mandatory caution about copper absorption and about infants and young children. It cannot say anything about colds or immunity using this route.
3. Why does the caution statement mention copper?
Sustained high zinc intake can interfere with copper absorption. Japan’s regulator requires this warning on every zinc Foods with Nutrient Function Claims label, and it is a genuine formulation consideration for long-duration products.
4. Which zinc form should a product use?
It depends on the format and the claim. Gluconate and citrate absorb similarly and better than oxide in published data; acetate is the form used in the pooled lozenge trials. None of this is a Japanese regulatory requirement — it is a formulation choice.
5. Why do zinc lozenges taste unusual?
Zinc has a metallic, sometimes bitter taste at the doses used in cold-relief trials, and bad taste was reported more often in the zinc groups of those trials. Flavouring and mouthfeel are real formulation work, not an afterthought.
Sources: “Zinc for the treatment of the common cold: a systematic review and meta-analysis of randomized controlled trials”, CMAJ 2012;184(10):E551 (PMID 22566526); “Zinc acetate lozenges for treating the common cold: an individual patient data meta-analysis”, British Journal of Clinical Pharmacology 2016 (PMID 27378206, PMCID PMC5061795); “Zinc for prevention and treatment of the common cold”, Cochrane Database of Systematic Reviews 2024 (PMID 38719213, PMC11078591); Consumer Affairs Agency, “栄養機能食品における栄養成分の下限値・上限値について” (January 2026) for current Foods with Nutrient Function Claims lower/upper limits; hfnet.nibn.go.jp (National Institutes of Biomedical Innovation, Health and Nutrition) for the notified function and caution wording for zinc; Japan’s Dietary Reference Intakes (2025 edition) for the tolerable upper intake level of zinc; NIH Office of Dietary Supplements Zinc Health Professional Fact Sheet for absorption comparisons between zinc gluconate, citrate and oxide, and for the US tolerable upper intake level. Checked on 25 September 2026.